In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help patients with type 2 diabetes manage blood sugar.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.

Weight loss drugs are seen as an easy option for dropping the pounds, but they are also expensive, and can have nasty side effects. But there’s another, cheaper way to suppress your appetite, says nut